A recent article in the Journal of Clinical Oncology recommends to oncologists that all patients with invasive breast cancer, including recurrent disease, should be tested for HER 2 status and these tests should adhere to specific criteria to define positive, equivocal, and negative results.
It’s often said that the HIV/AIDS epidemic has a woman’s face. The proportion of women infected with HIV has been on the rise for a decade; in sub-Saharan Africa, women constitute 60 percent of people living with the disease. While preventative drugs exist, they have often proven ineffective, especially in light of financial and cultural barriers in developing nations.
Hormone replacement therapy is one of the most well-evidenced and regulatory-approved treatment options for menopause, but what about natural alternatives?
Imagine that you are diagnosed with cancer at 24. On top of processing the enormity of your diagnosis at such a young age, you’re shuttled from one appointment to the next, coordinating your treatment plan in the quickest timeframe possible. Today, treatment discussions are more frequently including information regarding fertility preservation measures which gives hope to many patients about to start their arduous cancer treatment.
The reproductive community took note recently with the publication of research stating that ovarian tissue cryopreserved using a technique called vitrification, has resulted in a live human birth. Ovarian tissue cryopreservation is an experimental fertility preservation technique that involves the surgical removal of an ovary, freezing, and later thawing and transplantation when the woman is ready to have children. This technique is an option for women and girls who may not be able to undergo more established fertility preservation options but to-date only about 20 human live births have been reported using this technique.
Hormone replacement therapy is one of the most well-evidenced and regulatory-approved treatment options for menopause, but what about natural alternatives?
